HERMES PHARMA, a company involved in user-friendly oral dosage forms, will invest €25 million to further bolster its manufacturing capabilities. The investment will include new equipment, increased production and storage capacity, and greater operational efficiency to meet growing market demand for user-friendly oral dosage forms. The investment will add: large-volume coating equipment for taste-masking, filling and packaging lines for ODGs and instant drinks, expanded GMP manufacturing and s...